Articles Posted in Mass Torts

Nitrous oxide cartridges, often sold under names like Whip-Its, Galaxy Gas, and Baking Bad, are now at the center of a growing wave of lawsuits across the country. Our lawyers are handling claims against manufacturers, distributors, and retailers for serious nitrous oxide injuries.

What was marketed as a novelty or culinary product has become a common recreational inhalant, especially among young people. Repeated use is dangerous. It can cause neurological injury, psychiatric damage, spinal cord dysfunction, and in some cases, death. Nitrous oxide use is now showing up in medical records, emergency rooms, and court filings. This is a serious and escalating problem.

Lawsuits allege that companies failed to warn about known risks, marketed products in ways that encouraged abuse, and ignored clear signs of harm. Cases include personal injury and wrongful death claims, as well as proposed class actions arising from deceptive labeling and distribution practices. These claims could eventually be consolidated in a federal MDL for coordinated pretrial proceedings.

For sickle cell patients and families, Oxbryta was supposed to be a lifeline. Instead, it left many worse off–facing new health crises, hospitalizations, and in some cases, unthinkable loss. Now, Oxbryta lawsuits are uncovering what Pfizer knew and when it knew it.

Oxbryta is a prescription drug developed by Global Blood Therapeutics and later acquired by Pfizer. It was voluntarily recalled in September 2024 after new evidence revealed that it caused serious and potentially fatal complications, including vaso-occlusive crises and organ damage.

This page looks at Oxbryta lawsuits and their potential settlement value.

Oxbryta is a prescription drug made by Pfizer that was recalled in September 2024 after evidence revealed that it caused a number of very serious and potentially fatal health problems, including vaso-occlusive crisis and organ damage. Continue reading

Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.

Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.

This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.

The Cartiva toe implant is a synthetic cartilage device used to treat arthritis in the big toe. New evidence suggests that these implants are defectively designed and prone to failures that can result in pain, further surgery, and other injuries. Cartiva toe implant lawsuits are now being filed by individuals who experienced a premature failure of their implant.

We hoped to see Cartiva settlement payouts by 2025 as part of a global settlement. That has not happened. Unfortunately, this litigation is dragging on. But these lawsuits could reach a settlement at any time. You want to submit a case before that happens. So, if you have a claim, call us or another lawyer sooner rather than later.

Not many of these lawsuits have been filed.   But there are many more cases out there, and that is likely to change if there is no settlement soon. If you have a potential claim, call us today at 800-553-8082 or get a free consultation online.